Taken together, these results suggest that HGSL DHL extracts inhibit the NF-κB and ERK pathways and the transcriptional activation of NF-κB by reducing the nuclear localization of p65 in CRC cells. The gene discussed is NFKB1; the disease is colorectal carcinoma.